COMBINATION THERAPIES TARGETING TERT DEPENDENCY FOR CANCER THERAPY

• 收藏
• 分享

专利权人:

The Wistar Institute of Anatomy and Biology

发明人:

Jesse Villanueva

申请号：

US16354379

公开号：

US20190282600A1

申请日:

2019.03.15

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Pharmaceutical compositions and methods for the treatment of cancer are provided. In one embodiment the composition comprises a telomerase inhibitor and an agent that decreases or downregulates anti-oxidant response or induces oxidative stress.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/